Hypothesis Response guided therapy improves significantly the overall SVR in Hispanics
compared to historical control. There is no difference in SVR between patients with an
undetectable HCV RNA at week 8 and week 28 who received a 4 week lead-in of PR plus 24 weeks
of PR+BOC based treatment and patients with detectable HCV RNA at week 8 and undetectable HCV
RNA at week 24 who received a lead-in of PR plus 32 weeks PR+BOC followed by based therapy
and 12 weeks of PR.